Treatment-naïve High Risk Chronic Lymphocytic Leukemia
1 clinical trials · Condition
◉ Watch Treatment-naïve High Risk Chronic Lymphocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome (NCT04623541) | Genmab | 2020-11-25 |
Track Treatment-naïve High Risk Chronic Lymphocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.